Hemorrhoids remain one of the most common anorectal conditions worldwide, affecting millions with symptoms ranging from painless rectal bleeding in internal hemorrhoids to acute perianal swelling and thrombosis in external disease—and complex, recurrent challenges in mixed or advanced cases. Despite a crowded over-the-counter market offering creams, suppositories, and liquid formulations, many patients struggle with ineffective treatment due to mismatched product selection. Marketing claims often overshadow evidence-based pharmacology, leading users to rely on anecdote rather than pathophysiology—resulting in symptom recurrence, delayed healing, or unnecessary escalation of care.
Effective hemorrhoid management hinges not on delivery format or branding, but on aligning active ingredients with the underlying disease mechanism: vascular congestion, mucosal erosion, inflammatory infiltration, and impaired tissue repair. Contemporary medical-grade hemorrhoid products fall into four scientifically distinct categories—each defined by its core bioactive compound, molecular mechanism of action, and clinical indication. Understanding these distinctions enables rational, patient-centered therapy—whether for daily maintenance, acute flare control, postoperative recovery, or constitutional support.
Chitosan-based formulations: First-line, broad-spectrum mucosal protection and repair
Derived from deacetylated chitin (typically sourced from crustacean exoskeletons), chitosan is a naturally occurring cationic polysaccharide widely validated in wound care and anorectal medicine. When formulated as a water-soluble, high-purity medical-grade polymer—often combined with carbomer for optimized rheology—it functions as a multifunctional bioprotective agent. Upon contact with the moist anorectal mucosa or hemorrhoidal tissue, chitosan rapidly forms a breathable, hydrophilic biofilm that physically shields ulcerated or inflamed surfaces from fecal contamination, enzymatic irritation, and mechanical trauma. Its positive charge promotes platelet aggregation at microvascular rupture sites, delivering rapid, non-vasoconstrictive hemostasis—particularly effective for grade I–II internal hemorrhoids presenting with drip or toilet-paper spotting. Concurrently, chitosan downregulates pro-inflammatory cytokines—including TNF-α and IL-6—reducing venous congestion, edema, and discomfort. It also stimulates fibroblast proliferation and epithelial migration, accelerating mucosal regeneration and diminishing prolapse-associated engorgement over time. A representative example is *Meng Dafu Xi Mei Hemorrhoid Gel*, a Class II medical device approved for use across all hemorrhoid types—including postoperative wound conditioning. Its applicator-enabled rectal delivery ensures targeted application to internal hemorrhoidal cushions, while its non-irritating profile makes it suitable for sensitive populations, including pregnant individuals and older adults.
Mussel adhesive protein (MAP)-based agents: Targeted deep-tissue repair for moderate-to-severe disease and surgical recovery
Extracted from the byssal threads of marine mussels, mussel adhesive protein leverages catechol-rich amino acid motifs (e.g., dihydroxyphenylalanine) to achieve exceptional wet-surface adhesion—making it uniquely suited for the challenging anorectal environment. Unlike superficial protectants, MAP acts at the cellular and extracellular matrix level, functioning as a “biological sealant” for complex, deep-tissue injuries. In severe hemorrhoidal disease—such as grade III–IV prolapse with mucosal ulceration, strangulated or thrombosed external hemorrhoids, or post-hemorrhoidectomy wounds—MAP provides dual mechanistic benefits: first, it initiates physiological hemostasis by recruiting endogenous coagulation factors without inducing rebound vasodilation; second, it upregulates collagen synthesis and orchestrates orderly keratinocyte migration, shortening granulation phase duration and reducing hypertrophic scarring risk. Critically, MAP also dampens nociceptive signaling by transiently shielding exposed nerve endings from mechanical shear during defecation—significantly improving functional tolerance. *Kang Mei Hemorrhoid Suppository* exemplifies this class: designed specifically for patients with refractory bleeding, persistent prolapse, or early postoperative recovery, its sustained-release rectal formulation maintains therapeutic MAP concentration directly at the surgical site or deeply eroded hemorrhoidal tissue, supporting moist wound healing while mitigating infection risk through localized antimicrobial modulation.
Sodium alginate-composite liquids: Rapid-onset symptomatic control for acute exacerbations
Sodium alginate—a natural anionic polysaccharide derived from brown seaweed—undergoes instantaneous calcium-mediated gelation upon contact with physiological fluids, forming a highly elastic, water-retentive hydrogel film. This property underpins its utility in acute hemorrhoidal flares: the gel rapidly absorbs exudate from inflamed or thrombosed tissue, thereby reducing edema, heat, and tenderness within minutes. Its low-molecular-weight components penetrate superficial mucosal layers to occlude minor vascular leaks, while its lubricating surface minimizes friction-induced trauma during bowel movements. When compounded with humectants and mild anti-irritants, sodium alginate solutions offer versatile administration—topical spray, peri-anal rinse, or rectal instillation—ideal for on-the-go symptom interruption. *Jian Mei Qing Hemorrhoid Solution* leverages this mechanism for immediate relief in scenarios such as sudden thrombotic swelling, bright-red post-defecation bleeding, or perianal pruritus secondary to moisture retention. Its residue-free, non-staining profile enhances adherence in outpatient and occupational settings, serving as a critical “bridge” between acute intervention and longer-term restorative therapy.
Traditional Chinese herbal preparations: Systemic modulation of damp-heat and blood stasis patterns
Rooted in centuries of empirical practice and modern pharmacognosy, TCM-based hemorrhoid products integrate botanical actives—including *Sanguisorba officinalis* (radix sanguisorbae), *Sophora japonica* (huai jiao), borneol, calamine, and *Portulaca oleracea*—to address constitutional contributors to hemorrhoidal disease. These formulations operate via synergistic pathways: cooling and detoxifying (to counteract damp-heat accumulation), hemostatic and astringent (to reduce capillary fragility), and circulatory-enhancing (to resolve local stasis). Borneol improves transmucosal penetration, while tannin-rich herbs like *Dichroa febrifuga* (wu bei zi) decrease serous exudation and alleviate perianal maceration and pruritus. Though less potent for structural repair than biomaterial-based agents, these preparations provide valuable adjunctive support—particularly for patients with recurrent, low-grade symptoms linked to dietary indiscretion, sedentary lifestyle, or constitutional damp-heat. Their gentle, cumulative effect supports long-term homeostasis when integrated with behavioral modifications.
In summary, evidence-informed hemorrhoid management requires matching molecular pharmacology to clinical phenotype—not marketing hype. Chitosan-based products represent the highest-tier foundational option: safe, broadly indicated, and clinically substantiated across the full spectrum of non-emergent disease. For moderate-to-severe presentations or postoperative recovery, mussel adhesive protein offers unparalleled depth of tissue repair. Sodium alginate liquids fill a vital niche in acute symptom containment, while TCM preparations serve as complementary modulators of systemic contributors. Crucially, no topical agent substitutes for timely specialist evaluation in cases of massive hemorrhage, irreducible prolapse, necrotic tissue, or unrelenting pain—conditions demanding urgent surgical or procedural intervention. Sustainable hemorrhoid control ultimately rests on layered strategy: appropriate pharmacologic targeting, consistent adherence to bowel habit optimization, dietary fiber sufficiency, and avoidance of prolonged straining or sitting. With precise ingredient awareness, patients can move beyond trial-and-error toward truly personalized, physiology-driven care.